Part of Hong Kong stocks of innovative drugs have strengthened, with Fosun Pharma rising over 7%.

As of the deadline for the article, Fosun Pharma rose by 7.55%, JinTai Holding Group rose by 3.22%, Lianzhong Pharmaceutical rose by 2.35%, and Hainan Yedao Pharmaceutical-B rose by 1.14%.